Cargando…

Identification of molecular classification and gene signature for predicting prognosis and immunotherapy response in HNSCC using cell differentiation trajectories

Head and neck squamous cell carcinoma (HNSCC) is a highly heterogeneous malignancy with poor prognosis. This article aims to explore the clinical significance of cell differentiation trajectory in HNSCC, identify different molecular subtypes by consensus clustering analysis, and develop a prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Ji, Zheng, Sihan, He, Xinling, Huang, Yanlin, Hu, Lanxin, Qin, Fengfeng, Zhong, Lunkun, Li, Sen, Hu, Wenjian, Zhu, Jiali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701758/ https://www.ncbi.nlm.nih.gov/pubmed/36437265 http://dx.doi.org/10.1038/s41598-022-24533-7

Ejemplares similares

The mechanisms of biofilm antibiotic resistance in chronic rhinosinusitis: A review
por: Huang, Yanlin, et al.
Publicado: (2022)

Role and mechanism of actin-related protein 2/3 complex signaling in cancer invasion and metastasis: A review
por: Zheng, Sihan, et al.
Publicado: (2022)

Head and Neck Squamous Cell Carcinoma Subtypes Based on Immunologic and Hallmark Gene Sets in Tumor and Non-tumor Tissues
por: Yin, Ji, et al.
Publicado: (2022)

Hypoxia-mediated activation of hypoxia-inducible factor-1α in head and neck squamous cell carcinoma: A review
por: Hu, Lanxin, et al.
Publicado: (2023)

CD73 is associated with poor prognosis in HNSCC
por: Ren, Zhen-Hu, et al.
Publicado: (2016)

HNSCC: Tumour Antigens and Their Targeting by Immunotherapy
por: von Witzleben, Adrian, et al.
Publicado: (2020)

Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC
por: Chi, Hao, et al.
Publicado: (2022)

PD-L2 based immune signature confers poor prognosis in HNSCC
por: Qiao, Yu, et al.
Publicado: (2021)

Review of biomarkers for response to immunotherapy in HNSCC microenvironment
por: Chen, Shaoshi, et al.
Publicado: (2023)

miR-96-5p Suppresses the Progression of Nasopharyngeal Carcinoma by Targeting CDK1
por: Luo, Xiaoqin, et al.
Publicado: (2020)

Circadian rhythm-related genes index: A predictor for HNSCC prognosis, immunotherapy efficacy, and chemosensitivity
por: Chi, Hao, et al.
Publicado: (2023)

A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC
por: Ding, Yinghe, et al.
Publicado: (2023)

A signature of 17 immune-related gene pairs predicts prognosis and immune status in HNSCC patients
por: Jiang, Pan, et al.
Publicado: (2020)

Novel Stemness-Related Gene Signature Predicting Prognosis and Indicating a Different Immune Microenvironment in HNSCC
por: Luo, Yi, et al.
Publicado: (2022)

Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC
por: Rabasco Meneghetti, Asier, et al.
Publicado: (2022)

Comprehensive Analysis of mTORC1 Signaling Pathway–Related Genes in the Prognosis of HNSCC and the Response to Chemotherapy and Immunotherapy
por: Ding, Zhao, et al.
Publicado: (2022)

The neoadjuvant paradigm reinvigorated: a review of pre-surgical immunotherapy in HNSCC
por: Stafford, Margaret, et al.
Publicado: (2020)

Cancer stem/progenitor signatures refine the classification of clear cell renal cell carcinoma with stratified prognosis and decreased immunotherapy efficacy
por: Zhou, Peng, et al.
Publicado: (2022)

Model-assisted predictions on prognosis in HNSCC: do we learn?
por: van der Schroeff, Marc P., et al.
Publicado: (2010)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
por: Cohen, Ezra E. W., et al.
Publicado: (2019)

Immune Checkpoint Expression on Immune Cells of HNSCC Patients and Modulation by Chemo- and Immunotherapy
por: Puntigam, Lisa K., et al.
Publicado: (2020)

Colorectal Cancer Cell Differentiation Trajectory Predicts Patient Immunotherapy Response and Prognosis
por: Qin, Yuling, et al.
Publicado: (2022)

Decreased calpain 6 expression is associated with tumorigenesis and poor prognosis in HNSCC
por: Xiang, Yinzhou, et al.
Publicado: (2017)

TRIM24 Expression as an Independent Biomarker for Prognosis and Tumor Recurrence in HNSCC
por: Klapper, Luise, et al.
Publicado: (2022)

Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma
por: Wu, Gujie, et al.
Publicado: (2023)

Ferroptosis‐related gene signature predicts prognosis and immunotherapy in glioma
por: Wan, Rong‐Jun, et al.
Publicado: (2021)

A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection
por: Sharon, Shay, et al.
Publicado: (2021)

Identification of Prognosis Associated microRNAs in HNSCC Subtypes Based on TCGA Dataset
por: Chamorro Petronacci, Cintia M., et al.
Publicado: (2020)

PLAU and LAMC2 can predict a poor prognosis in patients with HNSCC
por: Guo, Zhi-chen, et al.
Publicado: (2023)

A Histone Acetylation Modulator Gene Signature for Classification and Prognosis of Breast Cancer
por: Long, Mengping, et al.
Publicado: (2021)

Predictive models for stage and risk classification in head and neck squamous cell carcinoma (HNSCC)
por: Kumar, Sugandh, et al.
Publicado: (2020)

How to Increase the Efficacy of Immunotherapy in NSCLC and HNSCC: Role of Radiation Therapy, Chemotherapy, and Other Strategies
por: Nardone, Valerio, et al.
Publicado: (2018)

Incidence and survival of HNSCC patients living with HIV compared with HIV-negative HNSCC patients
por: Haase, Katharina, et al.
Publicado: (2021)

Immunogenic cell death-related classifications guide prognosis and immunotherapy in osteosarcoma
por: Zong, Yuan, et al.
Publicado: (2023)

EHF is a novel regulator of cellular redox metabolism and predicts patient prognosis in HNSCC
por: Oyelakin, Akinsola, et al.
Publicado: (2022)

ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC
por: Alvarado, Diego, et al.
Publicado: (2017)

Differential gene expression analysis of HNSCC tumors deciphered tobacco dependent and independent molecular signatures
por: Shaikh, Inayatullah, et al.
Publicado: (2019)

Identification and Validation of an EMT-Related LncRNA Signature for HNSCC to Predict Survival and Immune Landscapes
por: Feng, Chunyu, et al.
Publicado: (2022)

Identification of a Novel Epithelial–Mesenchymal Transition Gene Signature Predicting Survival in Patients With HNSCC
por: Xin, Wei, et al.
Publicado: (2021)

Identification and validation of neurotrophic factor-related genes signature in HNSCC to predict survival and immune landscapes
por: Peng, Gaoge, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qgl41thvtk7aqtuua7bm279a8j